These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33852968)

  • 1. Oral inhalation for delivery of proteins and peptides to the lungs.
    Fröhlich E; Salar-Behzadi S
    Eur J Pharm Biopharm; 2021 Jun; 163():198-211. PubMed ID: 33852968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier-based strategies for targeting protein and peptide drugs to the lungs.
    Cryan SA
    AAPS J; 2005 Mar; 7(1):E20-41. PubMed ID: 16146340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of biotherapeutics by inhalation aerosol.
    Niven RW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):151-231. PubMed ID: 9501969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry powder inhalers for pulmonary drug delivery.
    Frijlink HW; De Boer AH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive delivery strategies for biologics.
    Anselmo AC; Gokarn Y; Mitragotri S
    Nat Rev Drug Discov; 2019 Jan; 18(1):19-40. PubMed ID: 30498202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein and peptide delivery to lungs by using advanced targeted drug delivery.
    Chellappan DK; Prasher P; Saravanan V; Vern Yee VS; Wen Chi WC; Wong JW; Wong JK; Wong JT; Wan W; Chellian J; Molugulu N; Prabu SL; Ibrahim R; Darmarajan T; Candasamy M; Singh PK; Mishra V; Shastri MD; Zacconi FC; Chakraborty A; Mehta M; Gupta PK; Dureja H; Gulati M; Singh SK; Gupta G; Jha NK; George Oliver BG; Dua K
    Chem Biol Interact; 2022 Jan; 351():109706. PubMed ID: 34662570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatment by inhalation of macromolecules--principles, problems, and examples.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():53-79. PubMed ID: 19218633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation techniques for high dose dry powders.
    Brunaugh AD; Smyth HDC
    Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry powder inhalers for optimal drug delivery.
    Newman SP
    Expert Opin Biol Ther; 2004 Jan; 4(1):23-33. PubMed ID: 14680466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary drug delivery systems: recent developments and prospects.
    Courrier HM; Butz N; Vandamme TF
    Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):425-98. PubMed ID: 12661699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.
    Crowder TM; Rosati JA; Schroeter JD; Hickey AJ; Martonen TB
    Pharm Res; 2002 Mar; 19(3):239-45. PubMed ID: 11934228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress of dry powder inhalation of proteins and peptides].
    Zhou JY; Zhang L; Mao SR
    Yao Xue Xue Bao; 2015 Jul; 50(7):814-23. PubMed ID: 26552141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery to the lungs from dry powder inhalers.
    Newman SP
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S17-20. PubMed ID: 12974538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of systemic diseases by inhalation of biomolecule aerosols.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():15-26. PubMed ID: 20134033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for non-invasive delivery of biologics.
    Chung SW; Hil-lal TA; Byun Y
    J Drug Target; 2012 Jul; 20(6):481-501. PubMed ID: 22632037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary drug delivery: novel pharmaceutical technologies breathe new life into the lungs.
    Nanjwade BK; Adichwal SA; Gaikwad KR; Parikh KA; Manvi FV
    PDA J Pharm Sci Technol; 2011; 65(5):513-34. PubMed ID: 22293840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.